Krzysztof Landa, M.D. Health Technology Assessment – right and wrong use of HTA for treatment of ultrarare diseases - Orphan Drug Act - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-12-08 11:13:50 Pharmaceuticals policy Rare disease Orphan Drug Act Health Medicine Health economics Drug discovery Orphan drug		Krzysztof Landa, M.D. Health Technology Assessment – right and wrong use of HTA for treatment of ultrarare diseases Add to Reading List Source URL: ec.europa.eu Download Document from Source Website File Size: 253,23 KB Share Document on Facebook

	UNO SGUARDO RARO – TERZA EDIZIONE Festival internazionale del film a tema malattie rare BANDO DI CONCORSO 2017 La terza edizione di Uno sguardo raro – The Rare Disease International Film Festival si svolgerà a Roma DocID: 1vml5 - View Document
	Rare Disease Registries: Advancing Disease Understanding, Treatments, and Cures CoRDS Christopher Jones DocID: 1vmdd - View Document
	What Is Addison’s? Addison’s Disease is a rare hormonal disorder which affects approximately 6 to 11 per 100,000 people. It affects men and women alike and occurs in all age groups, including children. Addison’s di DocID: 1v6s1 - View Document
	Cambridge International Rare Disease Summit 2016 Robinson College, Grange Road, Cambridge, CB3 9AN DocID: 1v0iU - View Document
	Gift Aid declaration – for past, present & future donations Rare Disease UK is an initiative of Genetic Alliance UK, registered charity numbersand SCO39299 Please treat as Gift Aid donations all DocID: 1uZQn - View Document